SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-2.83%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$332M
AUM Growth
+$332M
(+20%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
27.62%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
251
New
43
Increased
41
Reduced
62
Closed
33
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$40.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$31.8M |
| 3 |
Amgen
AMGN
|
$17.5M |
| 4 |
Eli Lilly
LLY
|
$15.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
$7.73M |
Top Sells
| 1 |
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
|
$12.8M |
| 2 |
SHPG
Shire pic
SHPG
|
$6.04M |
| 3 |
WGBS
WaferGen Bio-systems, Inc.
WGBS
|
$6.03M |
| 4 |
Abbott
ABT
|
$4.77M |
| 5 |
GNVC
GenVec, Inc.
GNVC
|
$4.46M |
Sector Composition
| 1 | Healthcare | 93.08% |
| 2 | Consumer Staples | 0.27% |
| 3 | Technology | 0.16% |
| 4 | Energy | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Traws Pharma
TRAW
$9.89M
| $1.03M | 0.06% | 452,804 +60,781 | +16% | +$138K |
|
|
SCMP
52
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.02M | 0.06% | +75,000 | New | +$1.02M |
|
53
Capricor Therapeutics
CAPR
$287M
| $990K | 0.06% | 372,046 +14,610 | +4% | +$38.9K |
|
54
Larimar Therapeutics
LRMR
$310M
| $986K | 0.06% | +310,000 | New | +$986K |
|
55
Lexicon Pharmaceuticals
LXRX
$400M
| $969K | 0.06% | +70,040 | New | +$969K |
|
|
AIM
56
AIM ImmunoTech Inc.
AIM
$6.64M
| $960K | 0.06% | 1,391,286 +39,436 | +3% | +$27.2K |
|
57
Rocket Pharmaceuticals
RCKT
$354M
| $921K | 0.05% | 150,930 +6,928 | +5% | +$42.3K |
|
|
RIBT
58
DELISTED
RiceBran Technologies
RIBT
| $902K | 0.05% | 875,286 +80,850 | +10% | +$83.3K |
|
59
Regenxbio
RGNX
$451M
| $898K | 0.05% | 48,400 -214,777 | -82% | -$3.98M |
|
|
BPTH
60
DELISTED
Bio-Path Holdings Inc
BPTH
| $896K | 0.05% | 664,046 -650,646 | -49% | -$878K |
|
|
CYTXW
61
DELISTED
Cytori Therapeutics Inc Warrant
CYTXW
| $866K | 0.05% | 1,273,712 +378,695 | +42% | +$257K |
|
|
PTN
62
DELISTED
Palatin Technologies
PTN
| $853K | 0.05% | +1,672,573 | New | +$853K |
|
63
Adverum Biotechnologies
ADVM
$64.6M
| $822K | 0.05% | 283,306 -119,297 | -30% | -$346K |
|
64
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $806K | 0.05% | +28,618 | New | +$806K |
|
|
VIRX
65
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $801K | 0.05% | +221,326 | New | +$801K |
|
66
Actinium Pharmaceuticals
ATNM
$55.5M
| $760K | 0.04% | 868,608 -514,021 | -37% | -$450K |
|
|
NSPRW
67
DELISTED
InspireMD, Inc. Warrants
NSPRW
| $726K | 0.04% | +1,210,106 | New | +$726K |
|
|
ONSIZ
68
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
| $726K | 0.04% | 930,272 +3,621 | +0.4% | +$2.83K |
|
|
GNMX
69
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $716K | 0.04% | 138,195 -3,782 | -3% | -$19.6K |
|
70
SPDR S&P Biotech ETF
XBI
$5.07B
| $693K | 0.04% | +11,700 | New | +$693K |
|
|
OCRX
71
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $690K | 0.04% | 328,632 -71,403 | -18% | -$150K |
|
72
Enlivex Therapeutics
ENLV
$25M
| $687K | 0.04% | 660,157 -123,900 | -16% | -$129K |
|
73
Armata Pharmaceuticals
ARMP
$90.6M
| $668K | 0.04% | 1,518,814 +997,436 | +191% | +$439K |
|
74
VistaGen Therapeutics
VTGN
$102M
| $658K | 0.04% | 176,384 -172,712 | -49% | -$644K |
|
|
ADYX
75
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $649K | 0.04% | 1,100,398 -221,328 | -17% | -$131K |
|